Breaking News: Medicare’s New AI-Driven Program Could Delay Critical Care for Millions—Here’s What You Need to Know
In a move that’s sparking both curiosity and concern, Medicare is rolling out a groundbreaking pilot program that will require prior approval for 17 specific health services, leveraging artificial intelligence tools. But here’s where it gets controversial: critics argue this could lead to unnecessary delays for seniors who rely on immediate care. Could this be a step toward efficiency, or a recipe for denied treatments?
The Wasteful and Inappropriate Service Reduction (WISeR) model is set to launch in six states—Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington—starting January 1, 2026. Under this program, healthcare providers must secure Medicare approval before patients can access certain services, a stark shift from traditional Medicare’s historically authorization-free approach. And this is the part most people miss: the program will run for six years, affecting 6.4 million Americans on traditional Medicare in these states.
Why the Fuss?
Medicare covers nearly 70 million seniors, and this pilot program marks a significant change. The Centers for Medicare & Medicaid Services (CMS) claim WISeR will “protect American taxpayers” by curbing unnecessary care. But critics worry the AI tools involved could lead to higher denial rates, especially since companies conducting reviews are paid to reduce costs. Is this a fair trade-off, or a risky gamble with seniors’ health?
The Full List of Affected Services
The 17 services requiring prior authorization include:
- Electrical nerve stimulators
- Sacral nerve stimulation for urinary incontinence
- Phrenic nerve stimulator
- Deep brain stimulation for essential tremor and Parkinson’s disease
- Vagus nerve stimulation
- Surgically induced lesions of nerve tracts
- Hypoglossal nerve stimulation for obstructive sleep apnea
- Epidural steroid injections (excluding facet joint injections)
- Percutaneous vertebral augmentation
- Cervical fusion surgery
- Arthroscopic lavage and debridement for knee osteoarthritis
- Incontinence control devices
- Diagnosis and treatment of impotence
- Percutaneous image-guided lumbar decompression for spinal stenosis
- Skin and tissue substitutes
- Bioengineered skin substitutes for chronic lower limb wounds
- Cellular/tissue-based products for lower limb wound care
The Debate Heats Up
CMS Administrator Dr. Mehmet Oz defends WISeR, stating it will “crush fraud, waste, and abuse” while modernizing Medicare. However, Kevin Thompson, CEO of 9i Capital Group, warns, “For seniors, the impact could be substantial, especially when immediate care is critical.” He highlights the added layers of bureaucracy, predicting more delays and denials. Abe Sutton, director of CMS’s Innovation Center, counters that low-value services often harm patients and inflate costs, making WISeR a necessary step.
What’s Next?
While the program aims to streamline care, many Americans are uneasy about AI’s role in decision-making. A 2024 Senate report found AI tools deny care at rates 16 times higher than human decisions. Alex Beene, a financial literacy instructor, notes that while the pilot is limited, recipients must stay informed. Will this program protect taxpayers, or will it leave seniors vulnerable?
Your Turn: What Do You Think?
Is WISeR a forward-thinking solution to cut waste, or a risky experiment that could harm seniors? Share your thoughts in the comments—we want to hear from you!
